30:T595,{"@context":"https://schema.org","@graph":[{"@type":"CollectionPage","@id":"https://www.pedestalhealth.com/resources/publications/","url":"https://www.pedestalhealth.com/resources/publications/","name":"Publications","description":"Explore Pedestal Health publications—peer-reviewed and scientific work on real-world evidence across hepatology, dermatology, and GI.","publisher":{"@id":"https://www.pedestalhealth.com/#organization"},"isPartOf":{"@id":"https://www.pedestalhealth.com/#website"}},{"@type":["Organization","MedicalOrganization"],"@id":"https://www.pedestalhealth.com/#organization","name":"Pedestal Health","url":"https://www.pedestalhealth.com/","description":"Pedestal Health delivers regulatory-grade real-world evidence for life sciences across hepatology, dermatology, and gastroenterology.","sameAs":["https://www.linkedin.com/company/pedestal-health"]},{"@type":"WebSite","@id":"https://www.pedestalhealth.com/#website","url":"https://www.pedestalhealth.com/","name":"Pedestal Health","description":"Pedestal Health delivers regulatory-grade real-world evidence for life sciences across hepatology, dermatology, and gastroenterology.","publisher":{"@id":"https://www.pedestalhealth.com/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://www.pedestalhealth.com/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]}31:T5155, 26:["$","div",null,{"className":"","children":[["$","script",null,{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"$30"}}],["$","svg",null,{"style":{"display":"none"},"aria-hidden":"true","children":["$","defs",null,{"dangerouslySetInnerHTML":{"__html":"$31"}}]}],"$L32","$L33","$L34","$L35","$L36"]}]

JCO Clinical Cancer Informatics — Publications

Publications

Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer

Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer